×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ORIC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/6
04:30 pm
oric
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2/5
04:01 pm
oric
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Medium
Report
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
1/13
08:42 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Medium
Report
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
1/12
08:30 am
oric
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Low
Report
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
1/9
06:10 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Medium
Report
Oric Pharmaceuticals (NASDAQ:ORIC) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
1/7
06:05 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Medium
Report
Oric Pharmaceuticals (NASDAQ:ORIC) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/6
04:05 pm
oric
ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/8
09:27 am
oric
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
High
Report
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2025
04:10 pm
oric
oric pharmaceuticals, inc.
BEAT
Report
2.3%
oric pharmaceuticals, inc.
8/12/2025
04:05 pm
oric
oric pharmaceuticals, inc.
MISS
Report
3.3%
oric pharmaceuticals, inc.
5/5/2025
04:05 pm
oric
oric pharmaceuticals, inc.
BEAT
Report
-11.4%
oric pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/21
12:31 pm
oric
Form SCHEDULE 13G Oric Pharmaceuticals, Filed by: BlackRock, Inc.
Medium
Report
Form SCHEDULE 13G Oric Pharmaceuticals, Filed by: BlackRock, Inc.
1/20
07:19 pm
oric
Form 4 Oric Pharmaceuticals, For: Jan 16 Filed by: Heyman Richard A.
Medium
Report
Form 4 Oric Pharmaceuticals, For: Jan 16 Filed by: Heyman Richard A.
1/16
04:57 pm
oric
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Medium
Report
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
1/16
04:44 pm
oric
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Medium
Report
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
1/6
04:49 pm
oric
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: You Angie
Medium
Report
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: You Angie
1/6
04:48 pm
oric
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Kunkel Lori Anne
Medium
Report
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Kunkel Lori Anne
1/6
04:47 pm
oric
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Hoerter Steven L.
Medium
Report
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Hoerter Steven L.
1/6
04:46 pm
oric
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Heyman Richard A.
Medium
Report
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: Heyman Richard A.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: